For the Inventor, By the Inventor

Enter assignee name

Barcelona, Spain

Laboratories Del Dr. Esteve S.a.

USPTO Granted Patents = 23

Forward Citations = 40

Loading Chart...

Loading Chart...

57 inventors (with patents filed for the assignee):

Jordi Frigola-Constansa (7 out of 40 patents)

Helmut Heinrich Buschmann (4 out of 59 patents)

Ramón Merce-Vidal (3 out of 7 patents)

4. Antoni Torrens Jover (3 out of 18 patents)

5. Ramon Merce-Vidal (3 out of 18 patents)

6. Blas Andaluz-Mataro (3 out of 6 patents)

7. Antonio Torrens-Jover (2 out of 8 patents)

8. Susana Yenes-Minguez (2 out of 6 patents)

9. Jordi Benet Buchholz (2 out of 6 patents)

10. Maria Rosa Cuberes-Altisent (2 out of 15 patents)

11. Joerg Holenz (2 out of 26 patents)

12. Nicolas Tesson (1 out of 21 patents)

13. Christian Brander (1 out of 6 patents)

14. Anuska Llano (1 out of 4 patents)

15. Beatriz Mothe Pujadas (1 out of 4 patents)

23 patents: Sort by Forward Citations

1. 9988425 - Immunogens for HIV vaccination (2018-06-05),

2. 9782483 - Sigma ligands for the prevention and/or treatment of emesis induced by chemotherapy or radiotherapy (2017-10-10),

3. 9617281 - Imidazo[2,1-b]thiazole derivatives, their preparation and use as medicaments (2017-04-11),

4. 9393220 - Co-crystals of tramadol and NSAIDs (2016-07-19),

5. 9241927 - Pharmaceutical compositions comprising sigma receptor ligands (2016-01-26),

6. 9051275 - 4-[-2-[[5-methyl-1-(2-naphtalenyl)-1H-pyrazol-3-yl]oxy]ethyl]morpholine hydrochloride polymorphs and solvates (2015-06-09),

7. 8492425 - 5-methyl-1-(naphthalen-2-yl)-1H-pyrazoles useful as sigma receptor inhibitors (2013-07-23),

8. 8410159 - Imidazole compounds having pharmaceutical activity towards the sigma receptor (2013-04-02),

9. 8362011 - Tricyclic triazolic compounds (2013-01-29),

10. 8293740 - Sigma receptor inhibitors (2012-10-23),

11. 8044053 - Sulfonamide substituted pyrazoline compounds, their preparation and use as CB1 modulators (2011-10-25),

12. 7553965 - [object Object] (2009-06-30),

13. 7452881 - Derivatives of sulphonamides, their preparation and use as medicaments (2008-11-18),

14. 7291728 - Spirolactams and their synthesis (2007-11-06),

15. 7176200 - Derivatives of sulphonamides, their preparation and use as medicaments (2007-02-13),

Laboratorios del Dr. Esteve S.A. is a leading pharmaceutical company headquartered in Barcelona, Spain. With over 50 years of experience, they specialize in developing innovative healthcare solutions in various therapeutic areas. Their mission is to improve people's quality of life through research, development, and commercialization of high-quality pharmaceutical products.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 2 2025

23 Patents

#24 in Barcelona

#83 in Spain

#26,773 in the World

Barcelona, Spain

Laboratories Del Dr. Esteve S.a.

Forward Citations = 40

57 inventors:

Jordi Frigola-Constansa (7 out of 40 patents)

Helmut Heinrich Buschmann (4 out of 59 patents)

Ramón Merce-Vidal (3 out of 7 patents)

4. Antoni Torrens Jover (3 out of 18 patents)

5. Ramon Merce-Vidal (3 out of 18 patents)

Please report any incorrect information to support@idiyas.com

Loading…